236 related articles for article (PubMed ID: 29378262)
1. A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity.
Silva BA; Leal MC; Farías MI; Avalos JC; Besada CH; Pitossi FJ; Ferrari CC
Brain Behav Immun; 2018 Mar; 69():515-531. PubMed ID: 29378262
[TBL] [Abstract][Full Text] [Related]
2. Environmental enrichment improves cognitive symptoms and pathological features in a focal model of cortical damage of multiple sclerosis.
Silva BA; Leal MC; Farías MI; Erhardt B; Galeano P; Pitossi FJ; Ferrari CC
Brain Res; 2020 Jan; 1727():146520. PubMed ID: 31669283
[TBL] [Abstract][Full Text] [Related]
3. Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target?
Silva BA; Ferrari CC
Rev Neurosci; 2019 Apr; 30(3):221-232. PubMed ID: 30048237
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
Lassmann H
Front Immunol; 2018; 9():3116. PubMed ID: 30687321
[TBL] [Abstract][Full Text] [Related]
5. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
6. Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis.
Brown JWL; Chowdhury A; Kanber B; Prados Carrasco F; Eshaghi A; Sudre CH; Pardini M; Samson RS; van de Pavert SH; Wheeler-Kingshott CG; Chard DT
Mult Scler; 2020 May; 26(6):679-687. PubMed ID: 30957691
[TBL] [Abstract][Full Text] [Related]
7. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
Magliozzi R; Howell O; Vora A; Serafini B; Nicholas R; Puopolo M; Reynolds R; Aloisi F
Brain; 2007 Apr; 130(Pt 4):1089-104. PubMed ID: 17438020
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
9. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
[TBL] [Abstract][Full Text] [Related]
10. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
11. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
[TBL] [Abstract][Full Text] [Related]
12. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review.
Filippi M; Preziosa P; Barkhof F; Chard DT; De Stefano N; Fox RJ; Gasperini C; Kappos L; Montalban X; Moraal B; Reich DS; Rovira À; Toosy AT; Traboulsee A; Weinshenker BG; Zeydan B; Banwell BL; Rocca MA
JAMA Neurol; 2021 Mar; 78(3):351-364. PubMed ID: 33315071
[TBL] [Abstract][Full Text] [Related]
14. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi SR; Howell OW; Carassiti D; Magliozzi R; Gveric D; Muraro PA; Nicholas R; Roncaroli F; Reynolds R
Brain; 2012 Oct; 135(Pt 10):2925-37. PubMed ID: 22907116
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
16. Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosis.
Bonnan M; Money P; Desblache P; Marasescu R; Puvilland LM; Demasles S; Dahan C; Krim E; Tucholka A; Doyle S; Barroso B
Neurol Sci; 2021 May; 42(5):1959-1961. PubMed ID: 32995987
[TBL] [Abstract][Full Text] [Related]
17. Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T.
Louapre C; Govindarajan ST; Giannì C; Langkammer C; Sloane JA; Kinkel RP; Mainero C
Neurology; 2015 Nov; 85(19):1702-9. PubMed ID: 26468411
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
[TBL] [Abstract][Full Text] [Related]
19. B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
Fraussen J; de Bock L; Somers V
Autoimmun Rev; 2016 Sep; 15(9):896-9. PubMed ID: 27396817
[TBL] [Abstract][Full Text] [Related]
20. Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Kallaur AP; Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Lopes J; de Carvalho Jennings Pereira WL; de Meleck Proença C; Borelli SD; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2017 May; 54(4):2950-2960. PubMed ID: 27023227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
